This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
An Ongoing Phase 2 Study Of Hm15912, A Novel Long-Acting Glucagon-Like Peptide 2(Glp-2) Analog For Short Bowel Syndrome-Intestinal Failure (Sbs-If) Patients. (April 2023)
Record Type:
Journal Article
Title:
An Ongoing Phase 2 Study Of Hm15912, A Novel Long-Acting Glucagon-Like Peptide 2(Glp-2) Analog For Short Bowel Syndrome-Intestinal Failure (Sbs-If) Patients. (April 2023)
Main Title:
An Ongoing Phase 2 Study Of Hm15912, A Novel Long-Acting Glucagon-Like Peptide 2(Glp-2) Analog For Short Bowel Syndrome-Intestinal Failure (Sbs-If) Patients